Meaningful Gait Speed Improvement During the First 60 Days Poststroke: Minimal Clinically Important Difference

被引:334
|
作者
Tilson, Julie K. [1 ]
Sullivan, Katherine J. [2 ]
Cen, Steven Y. [1 ]
Rose, Dorian K. [3 ]
Koradia, Cherisha H.
Azen, Stanley P. [4 ]
Duncan, Pamela W. [5 ,6 ]
机构
[1] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA
[2] Univ So Calif, Phys Therapy Program, Los Angeles, CA 90089 USA
[3] Univ Florida, Dept Phys Therapy, Gainesville, FL USA
[4] Univ So Calif, Div Biostat, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA
[5] Duke Univ, Dept Community & Family Med, Div Doctor Phys Therapy, Durham, NC USA
[6] Duke Univ, Sch Nursing, Durham, NC USA
来源
PHYSICAL THERAPY | 2010年 / 90卷 / 02期
关键词
MODIFIED-RANKIN-SCALE; PHYSICAL PERFORMANCE-MEASURES; BARTHEL INDEX; HEALTH-STATUS; DISABILITY MEASURES; TIME-COURSE; STROKE; RELIABILITY; REHABILITATION; RECOVERY;
D O I
10.2522/ptj.20090079
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background. When people with stroke recover gait speed, they report improved function and reduced disability. However, the minimal amount of change in gait speed that is clinically meaningful and associated with an important difference in function for people poststroke has not been determined. Objective. The purpose of this study was to determine the minimal clinically important difference (MCID) for comfortable gait speed (CGS) associated with an improvement in the modified Rankin Scale (mRS) score for people between 20 to 60 days poststroke. Design. This was a prospective, longitudinal, cohort study. Methods. The participants in this Study were 283 people with first-time stroke prospectively enrolled in the ongoing Locomotor Experience Applied Post Stroke (LEAPS) multi-site randomized clinical trial. Comfortable gait speed was measured and mRS scores were obtained at 20 and 60 days poststroke. improvement of >= 1 on the mRS was used to detect meaningful change in disability level. Results. Mean (SD) CGS was 0.18 (0.16) m/s at 20 days and 0.39 (0.22) m/s at 60 days poststroke. Among all participants, 47.3% experienced an improvement in disability level >= 1. The MCID was estimated as an improvement in CGS of 0.16 m/s anchored to the mRS. Limitations. Because the mRS is not a gait-specific measure of disability, the estimated MCID for CGS was only 73.9% sensitive and 57.0% specific for detecting improvement in mRS scores. Conclusions. We estimate that the MCID for gait speed among patients with Subacute stroke and severe gait speed impairments is 0.16 m/s. Patients with subacute stroke who increase gait speed >= 0.16 m/s are more likely to experience a meaningful improvement in disability level than those who do not. Clinicians can use this reference value to develop goals and interpret progress in patients with subacute stroke.
引用
收藏
页码:196 / 208
页数:13
相关论文
共 50 条
  • [41] Evaluating Physical Outcomes in Acute Respiratory Distress Syndrome Survivors: Validity, Responsiveness, and Minimal Important Difference of 4-Meter Gait Speed Test
    Chan, Kitty S.
    Friedman, Lisa Aronson
    Dinglas, Victor D.
    Hough, Catherine L.
    Morris, Peter E.
    Mendez-Tellez, Pedro A.
    Jackson, James C.
    Ely, E. Wesley
    Hopkins, Ramona O.
    Needham, Dale M.
    CRITICAL CARE MEDICINE, 2016, 44 (05) : 859 - 868
  • [42] At Completion of a Multidisciplinary Treatment Program, Are Psychophysical Variables Associated with a VAS Improvement of 30% or More, a Minimal Clinically Important Difference, or an Absolute VAS Score Improvement of 1.5 cm or More?
    Fishbain, David A.
    Gao, Jinrun
    Lewis, John E.
    Zhang, Lei
    PAIN MEDICINE, 2016, 17 (04) : 781 - 789
  • [43] Preoperative Disability Influences Effectiveness of Minimal Clinically Important Difference and Patient Acceptable Symptom State in Predicting Patient Improvement Following Cervical Spine Surgery
    Shahi, Pratyush
    Maayan, Omri
    Subramanian, Tejas
    Singh, Nishtha
    Singh, Sumedha
    Araghi, Kasra
    Tuma, Olivia
    Asada, Tomoyuki
    Korsun, Maximilian
    Sheha, Evan
    Dowdell, James
    Qureshi, Sheeraz A.
    Iyer, Sravisht
    GLOBAL SPINE JOURNAL, 2023,
  • [44] Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy
    Miller, Jessa E.
    Taylor-Cousar, Jennifer L.
    Overdevest, Jonathan B.
    Khatiwada, Aastha
    Mace, Jess C.
    Alt, Jeremiah A.
    Bodner, Todd E.
    Chowdhury, Naweed I.
    DiMango, Emily A.
    Eshaghian, Patricia H.
    Getz, Anne E.
    Gudis, David A.
    Han, Ethan J.
    Hwang, Peter H.
    Keating, Claire L.
    Khanwalkar, Ashoke
    Kimple, Adam J.
    Lee, Jivianne T.
    Li, Douglas
    Markarian, Karolin
    Norris, Meghan
    Nayak, Jayakar V.
    Owens, Cameran
    Patel, Zara M.
    Poch, Katie
    Schlosser, Rodney J.
    Smith, Kristine A.
    Smith, Timothy L.
    Soler, Zachary M.
    Suh, Jeffrey D.
    Tervo, Jeremy P.
    Turner, Grant A.
    Wang, Marilene B.
    Saavedra, Milene T.
    Beswick, Daniel M.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (06) : 1079 - 1087
  • [45] How Should We Define Meaningful Improvement? A Commentary on Minimal Clinically Important Difference Assessment for Hip Disability and Osteoarthritis Outcome Score for Joint Replacement and Knee Injury and Osteoarthritis Outcome Score for Joint Replacement in Total Joint Arthroplasty
    Omran, Kareem
    Schwarzkopf, Ran
    JOURNAL OF ARTHROPLASTY, 2025, 40 (03): : 545 - 549
  • [46] The minimal clinically important difference in the treadmill six-minute walk test in active women with breast cancer during and after oncological treatments
    Cantarero-Villanueva, Irene
    Postigo-Martin, Paula
    Granger, Catherine L.
    Waterland, Jamie
    Galiano-Castillo, Noelia
    Denehy, Linda
    DISABILITY AND REHABILITATION, 2023, 45 (05) : 871 - 878
  • [47] Guidelines for Proper Reporting of Clinical Significance, Including Minimal Clinically Important Difference, Patient Acceptable Symptomatic State, Substantial Clinical Benefit, and Maximal Outcome Improvement
    Harris, Joshua D.
    Brand, Jefferson C.
    Cote, Mark
    Waterman, Brian
    Dhawan, Aman
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2023, 39 (02): : 145 - 150
  • [48] Quantifying success after first revision reverse total shoulder arthroplasty: the minimal clinically important difference, substantial clinical benefit, and patient acceptable symptomatic state
    Hao, Kevin A.
    Hones, Keegan M.
    O'Keefe, Daniel S.
    Saengchote, Supreeya A.
    Burns, Madison Q.
    Wright, Jonathan O.
    Wright, Thomas W.
    Farmer, Kevin W.
    Struk, Aimee M.
    Simovitch, Ryan W.
    Schoch, Bradley S.
    King, Joseph J.
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2023, 32 (10) : e516 - e527
  • [49] The quality of spine surgery from the patient’s perspective: Part 2. Minimal clinically important difference for improvement and deterioration as measured with the Core Outcome Measures Index
    A. F. Mannion
    F. Porchet
    F. S. Kleinstück
    F. Lattig
    D. Jeszenszky
    V. Bartanusz
    J. Dvorak
    D. Grob
    European Spine Journal, 2009, 18 : 374 - 379
  • [50] The quality of spine surgery from the patient's perspective: Part 2. Minimal clinically important difference for improvement and deterioration as measured with the Core Outcome Measures Index
    Mannion, A. F.
    Porchet, F.
    Kleinstueck, F. S.
    Lattig, F.
    Jeszenszky, D.
    Bartanusz, V.
    Dvorak, J.
    Grob, D.
    EUROPEAN SPINE JOURNAL, 2009, 18 : S374 - S379